FDA Import Refusal 1FX-5554870-4/50002/1 — REMAX PHARMACEUTICALS LTD
The FDA refused shipment 1FX-5554870-4/50002/1 from REMAX PHARMACEUTICALS LTD (India) on May 14, 2026. The refused product falls under Drugs and Biologics — LEVOFLOXACIN (ANTI-BACTERIAL, PART III). Cited charges: 118,75
Refusal Details
- Date
- May 14, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61HCA43 LEVOFLOXACIN (ANTI-BACTERIAL, PART III)
- Charges
- 118,75